Salute e Benessere
Endometriosis Treatment Market to Surge to US$ 3.1 Billion by 2034: Innovations in Surgical Procedures and Fertility-Preserving Medications Drive Market Growth | TMR
Hormone therapies such as GnRH agonists and antagonists, aromatase inhibitors, and other hormonal medicines, are crucial in controlling endometriosis-related pain. Newer medications, such as GnRH antagonists like Elagolix and Letrozole, have showed promise, especially in terms of pain relief and fertility outcomes.
Despite the range of treatment choices, the market faces obstacles in providing effective long-term solutions that do not jeopardize fertility. Drugs such as Elagolix, which was licensed by the FDA in 2018, have considerable potential but require additional investigation, particularly in terms of its usage in pre-treatment prior to in vitro fertilization. Elagolix's ongoing clinical research (NCT04173169) is expected to provide useful insights once completed in September 2024 .
The market is also looking into selective estrogen receptor modulators (SERMs), such as SR-16234, which show promise due to their unique receptor action but require further clinical validation. Furthermore, established treatments like Danazol are still being contested due to their negative effects, whereas medications like Gestrinone are less often used and unavailable in areas such as the United States .
Players in the endometriosis treatment landscape are seeking fast track approvals for their products from regulatory authorities. Given the highly complex nature of this treatment, providers have to comply with stringent guidelines before they make the said approach available to end users. Some prominent endometriosis treatment providers are given below:
, a global registered at Wilmington, Delaware , United States , provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
:
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
+1-518-618-1030
: 866-552-3453
https://www.transparencymarketresearch.com
sales@transparencymarketresearch.com
LinkedIn Twitter Blog YouTube
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/endometriosis-treatment-market-to-surge-to-us-3-1-billion-by-2034-innovations-in-surgical-procedures-and-fertility-preserving-medications-drive-market-growth--tmr-302207553.html